Article info

Download PDFPDF
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer
  1. Address correspondence and reprint requests to Patricia Pautier, MD, Gustave Roussy Cancer Campus, 114 Rue Édouard Vaillant, 94805 Villejuif, France. E-mail: patricia.pautier{at}gustaveroussy.fr.

Citation

Pautier P, Vergote I, Joly F, et al
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer

Publication history

  • Received October 14, 2015
  • Accepted August 31, 2016
  • First published February 1, 2017.
Online issue publication 
February 01, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.